IL6 and rheumatoid arthritis: Given the abundancy of IL-6 and MCP1 in RA synovial fluid and the role of synovial fibroblasts in their production (39), jakinibs might importantly diminish the pro-inflammatory cytokine content in synovial fluid in RA.